Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
94,974,795
-
Share change
-
-13,115,545
-
Total reported value
-
$232,855,173
-
Put/Call ratio
-
94%
-
Price per share
-
$2.45
-
Number of holders
-
194
-
Value change
-
-$147,581,517
-
Number of buys
-
120
-
Number of sells
-
126
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2025
As of 30 Jun 2025,
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,974,795 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, MAVERICK CAPITAL LTD, BlackRock, Inc., VANGUARD GROUP INC, SUVRETTA CAPITAL MANAGEMENT, LLC, MPM BIOIMPACT LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Newtyn Management, LLC.
This page lists
195
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.